C75.1: Malignant neoplasm of pituitary gland
C75.1 is a billable, specific ICD-10-CM code for malignant neoplasm of pituitary gland. It is valid for submission on a claim.
Check C75.1 with the rest of the claim: free scrubberExcludes1 inherited from the categories above C75.1
A category’s note binds every code beneath it.
Written on C75: Malignant neoplasm of other endocrine glands and related structures
- malignant carcinoid tumors (C7A.0-)
- malignant neoplasm of adrenal gland (C74.-)
- malignant neoplasm of endocrine pancreas (C25.4)
- malignant neoplasm of islets of Langerhans (C25.4)
- malignant neoplasm of ovary (C56.-)
- malignant neoplasm of testis (C62.-)
- malignant neoplasm of thymus (C37)
- malignant neoplasm of thyroid gland (C73)
- malignant neuroendocrine tumors (C7A.-)
Risk adjustment
C75.1 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 20 Lung and Other Severe Cancers1.136 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.
Medicare coverage
C75.1 is named in 65 Medicare coverage policies: 65 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
- A53101Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update
- A54188Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID®
- A54386Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update
Alphabetic index entries that lead here
- Adenocarcinoma›acidophil›unspecified site
- Adenocarcinoma›basophil›unspecified site
- Adenocarcinoma›chromophobe›unspecified site
- Adenocarcinoma›eosinophil›unspecified site
- Carcinoma›acidophil›unspecified site
- Carcinoma›acidophil-basophil, mixed›unspecified site
- Carcinoma›basophil›unspecified site
- Carcinoma›basophil-acidophil, mixed›unspecified site
- Carcinoma›chromophobe›unspecified site
- Carcinoma›eosinophil›unspecified site
- Adenocarcinoma›mucoid›cell›unspecified site
- Carcinoma›mucoid›cell›unspecified site
Code history
Unchanged in every release from FY2024 to FY2027.
Other codes under C75
- C75.0Malignant neoplasm of parathyroid gland
- C75.2Malignant neoplasm of craniopharyngeal duct
- C75.3Malignant neoplasm of pineal gland
- C75.4Malignant neoplasm of carotid body
- C75.5Malignant neoplasm of aortic body and other paraganglia
- C75.8Malignant neoplasm with pluriglandular involvement, unspecified
- C75.9Malignant neoplasm of endocrine gland, unspecified